Das, Ishani http://orcid.org/0000-0002-2019-8072
Chen, Huiqin
Maddalo, Gianluca http://orcid.org/0000-0003-2297-6488
Tuominen, Rainer
Rebecca, Vito W.
Herlyn, Meenhard http://orcid.org/0000-0003-0839-0739
Hansson, Johan
Davies, Michael A. http://orcid.org/0000-0002-0977-0912
Egyházi Brage, Suzanne http://orcid.org/0000-0002-0524-2346
Funding for this research was provided by:
Dr. Miriam and Sheldon G. Adelson Medical Research Foundation
U.S. Department of Health & Human Services | NIH | National Cancer Institute (U54 CA224070 and P01)
Cancerfonden
Radiumhemmets Forskningsfonder
Knut och Alice Wallenbergs Stiftelse
Article History
Received: 27 June 2020
Revised: 18 September 2020
Accepted: 21 September 2020
First Online: 20 October 2020
Conflict of interest
: M.A.D. has been a consultant to Roche/Genentech, Array, Novartis, BMS, GSK, Sanofi-Aventis, and Vaccinex, and he has been the PI of funded research grants to his institution by Roche/Genentech, GSK, Sanofi-Aventis, Merck, Myriad, and Oncothyreon. The remaining authors declare no conflict of interest.